AstraZeneca PLC (AZN)
206.61
+1.67
(+0.81%)
USD |
NYSE |
Feb 24, 16:00
205.88
-0.73
(-0.35%)
Pre-Market: 08:17
AstraZeneca Research and Development Expense (Quarterly) : 3.725B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GSK Plc | 3.112B |
| Mereo BioPharma Group Plc | 4.243M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Biodexa Pharmaceuticals Plc | -- |
| Bicycle Therapeutics Plc | 65.63M |